Director, Field Market Access

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. Beam has assembled a platform with integrated gene editing, delivery, and internal manufacturing capabilities. The company’s suite of gene editing technologies is anchored by base editing, a proprietary technology designed to enable precise, predictable, and efficient single-base changes at targeted genomic sequences without making double-stranded breaks in the DNA. This approach has the potential to enable a wide range of therapeutic editing strategies across Beam’s diversified portfolio. Beam is a values-driven organization focused on cutting-edge science and providing life-long cures to patients suffering from serious diseases.

About the Role

The Director, US Field Market Access will lead regional US Field Market Access efforts across the Beam portfolio. This role will engage Treatment Centers and Payers on contracting, pricing strategy, affordability, and accessibility, playing a key part in driving coverage for Beam’s first commercial product, risto-cel, an ex vivo gene therapy for Sickle Cell Disease. Multiple positions are available nationwide.

Responsibilities

• Execute Market Access Strategies for the Beam portfolio with Payers and Treatment Centers, including communicating economic value propositions.
• Negotiate directly with Commercial and Government Payers to ensure pricing and coverage for the Beam portfolio, potentially including managed Medicaid and Medicaid FFS.
• Educate providers on local payer trends, appropriate billing and coding for gene therapy, and support offices for individual patient reimbursement journeys, including troubleshooting reimbursement concerns.
• Monitor, analyze, and influence local payer trends in rare disease and gene therapy to ensure an environment that supports innovation in affordability and accessibility.
• Provide training and education programs on reimbursement best practices and health policy issues to internal and external stakeholders, such as Treatment Centers.
• Work seamlessly with cross-functional field pod (Medical Affairs, Gene Therapy Operations, Key Account Management) to support access and coverage of Beam’s portfolio.
• Develop local/regional relationships with professional societies, medical associations, advocacy groups, thought leaders, and trade groups to drive comprehensive coverage and adequate payment.

Qualifications

• Bachelor’s degree required; advanced degree preferred.
• 10+ years of progressive experience in the pharmaceutical or biotech industry with 5+ years in market access, including field roles.
• Hospital and payer experience establishing coverage policies for complex therapies required.
• Demonstrated success in building and managing relationships with payers and financial decision-makers in Treatment Centers.
• Established relationships with payers (Commercial payers required; Medicaid preferred).
• Buy & bill experience required; experience in cell or gene therapy preferred.
• Experience working in local, cross-functional field teams, including Key Account Managers, MSLs, and Patient Operations.
• Excellent communication, presentation, and negotiation skills.
• Proficiency with CRM systems, PowerPoint, and Excel.
• Willingness to travel approximately 50% of the time as needed.

Team Structure

Beam’s field team operates through an account-based pod model, grouping cross-functional specialists to manage accounts from lead to close. Key roles include:

• Director, Key Account Manager (KAM): Owns the integrated account strategy, account plan, and overall account performance.
• Director, Field Market Access: Owns access, reimbursement, and payer engagement.
• Associate Director/Director, Gene Therapy Operations (GTO): Owns site operational readiness and apheresis and patient logistics execution.

Each role and team is expected to work cross-functionally while maintaining clear functional accountability.